Mapping genetic modulators of amyloid plaque deposition in TgCRND8 transgenic mice.

Alzheimer's disease (AD) is a complex disorder for which various in vivo models exist. The TgCRND8 mouse, transgenic for the human amyloid precursor protein, is an aggressive early onset model of brain amyloid deposition. Preliminary studies revealed that when the transgene is expressed on an A/J genetic background, these mice not only survive longer but also deposit less parenchymal amyloid-beta (Abeta) peptides as compared to those on a C57BL/6 background. We performed a genome-wide study of an F2 intercross between TgCRND8 on an A/J background and C57BL/6 mice, to identify genetic modulators of amyloid accumulation and deposition. We identified four highly significant QTLs that together account for 55% of the phenotypic variance in the number of plaques (Thioflavin S). QTLs were found on the distal part of chromosome 4 with an LOD score of 8.1 at D4Mit251, on chromosome 11 with an LOD score of 5.5 at D11Mit242, on chromosome 9 with an LOD score of 5.0 at D9Mit336 and on the proximal part of chromosome 8 with an LOD score of 4.5 at D8Mit223. A/J alleles at these loci are protective and all decreased the amount of Abeta deposition. Interestingly, the QTL on chromosome 11 is also significantly linked to the levels of brain Abeta(42) and Abeta(40). Although these QTLs do not control the levels of plasmatic Abeta, other regions on chromosomes 1 and 6 show significant linkage. Further characterization of these QTL regions may lead to the identification of genes involved in the pathogenesis of AD.

[1]  T. Wight,et al.  Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .

[2]  R. Tanzi,et al.  The genetic epidemiology of neurodegenerative disease. , 2005, The Journal of clinical investigation.

[3]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Younkin,et al.  Genetic background regulates β-amyloid precursor protein processing and β-amyloid deposition in the mouse , 2003 .

[5]  P. S. St George-Hyslop,et al.  In vivo reduction of amyloid-beta by a mutant copper transporter. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Morissette,et al.  Inflammation occurs early during the Aβ deposition process in TgCRND8 mice , 2004, Neurobiology of Aging.

[7]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[8]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[9]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[10]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[11]  M. Owen,et al.  Full genome screen for Alzheimer disease: stage II analysis. , 2002, American journal of medical genetics.

[12]  S. Turner,et al.  Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695* , 2001, The Journal of Biological Chemistry.

[13]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Younkin,et al.  Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse. , 2003, Human molecular genetics.

[15]  G. Schellenberg,et al.  Positional Cloning of the Werner's Syndrome Gene , 1996, Science.

[16]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[17]  K. Manly,et al.  Map Manager QTX, cross-platform software for genetic mapping , 2001, Mammalian Genome.

[18]  S. Younkin,et al.  Identification of loci determining susceptibility to the lethal effects of amyloid precursor protein transgene overexpression. , 2004, Human molecular genetics.

[19]  D. Westaway,et al.  In vivo reduction of amyloid-β by a mutant copper transporter , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[21]  T. Wight,et al.  Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. , 1997, Journal of neurochemistry.

[22]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[23]  H. Soininen,et al.  Genome-wide linkage disequilibrium mapping of late onset Alzheimer's disease in Finland , 2000, Neurobiology of Aging.

[24]  M. Albert,et al.  Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.

[25]  M. Pericak-Vance,et al.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. , 1991, American journal of human genetics.

[26]  D. Borchelt,et al.  Genetic modification of the phenotypes produced by amyloid precursor protein overexpression in transgenic mice. , 1997, Human molecular genetics.

[27]  J. Rommens,et al.  Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene , 1995, Nature.

[28]  R. Tanzi,et al.  Alzheimer's disease: one disorder, too many genes? , 2004, Human molecular genetics.

[29]  M. Hosokawa,et al.  Amyloidosis Modifier Genes in the Less Amyloidogenic A/J Mouse Strain , 2003, Laboratory Investigation.

[30]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .